Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer
ClinicalTrials.gov study NCT03432598. IPD Sharing: YES. Countries: 1. Publications: 1.
Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406
ClinicalTrials.gov study NCT04467684. IPD Sharing: NO. Countries: 1. Publications: 2.
Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanom
ClinicalTrials.gov study NCT01176474. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
ClinicalTrials.gov study NCT05659186. IPD Sharing: Not stated. Countries: 1. Publications: 15.
The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients
ClinicalTrials.gov study NCT06357806. IPD Sharing: NO. Countries: 1. Publications: 1.
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05334329. IPD Sharing: Not stated. Countries: 1. Publications: 2.
PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor
ClinicalTrials.gov study NCT03615313. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC
ClinicalTrials.gov study NCT05332496. IPD Sharing: NO. Countries: 1. Publications: 4.
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
ClinicalTrials.gov study NCT04812002. IPD Sharing: NO. Countries: 1. Publications: 8.
A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC
ClinicalTrials.gov study NCT03394287. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC
ClinicalTrials.gov study NCT05332821. IPD Sharing: NO. Countries: 1. Publications: 5.
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT06461910. IPD Sharing: NO. Countries: 1. Publications: 0.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ClinicalTrials.gov study NCT06758401. IPD Sharing: YES. Countries: 27. Publications: 1.
An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD
ClinicalTrials.gov study NCT03994328. IPD Sharing: Not stated. Countries: 3. Publications: 14.
Assessment of Bioimpedance and Vitamin D and LV Mass in PD Patients (FLUID Study)
ClinicalTrials.gov study NCT01045980. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042
ClinicalTrials.gov study NCT02220894. IPD Sharing: YES. Countries: 0. Publications: 5.
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
ClinicalTrials.gov study NCT07138560. IPD Sharing: NO. Countries: 1. Publications: 3.
Cerebral Contributions to Symptom Progression in PD
ClinicalTrials.gov study NCT05169827. IPD Sharing: YES. Countries: 1. Publications: 12.
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
ClinicalTrials.gov study NCT02735239. IPD Sharing: NO. Countries: 1. Publications: 0.
Early Parkinson's Disease (PD) Cross-Sectional
ClinicalTrials.gov study NCT00817453. IPD Sharing: Not stated. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.